The 3 Small CRISPR Biotechs That Could Cure 10,000 Diseases Post author:Sam Post published:February 4, 2018 Post category:BioPharma A look at three small biotech companies that appear to be leading the CRISPR race. Source: BioSpace You Might Also Like SpinalCyte, LLC Receives New Japanese Patent July 20, 2017 5 Biotechs Drawing Buyout Buzz in 2018 January 23, 2018 Gilead Commits $100M to Tackle the HIV/AIDS Epidemic in the Southern U.S. December 3, 2017
